Osaic Holdings’s NeuroOne Medical Technologies NMTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$273 Hold
58
﹤0.01% 7522
2025
Q4
$266 Sell
58
-152
-72% -$692 ﹤0.01% 7541
2025
Q3
$956 Hold
210
﹤0.01% 7370
2025
Q2
$843 Hold
210
﹤0.01% 7212
2025
Q1
$1.07K Hold
210
﹤0.01% 6793
2024
Q4
$1.04K Hold
210
﹤0.01% 6831
2024
Q3
$1.25K Hold
210
﹤0.01% 6772
2024
Q2
$1.01K Buy
210
+152
+262% +$955 ﹤0.01% 6813
2024
Q1
$420 Hold
58
﹤0.01% 6851
2023
Q4
$553 Sell
58
-59
-50% -$435 ﹤0.01% 6879
2023
Q3
$623 Buy
117
+59
+102% +$395 ﹤0.01% 6948
2023
Q2
$420 Hold
58
﹤0.01% 7087
2023
Q1
$563 Hold
58
﹤0.01% 7104
2022
Q4
$0 Buy
+58
New +$519 ﹤0.01% 7354

Other funds holding NMTC

Osaic Holdings's NMTC Position: Q1 2026 in Review

Osaic Holdings held its NeuroOne Medical Technologies (NMTC) position steady in Q1 2026 at 58 shares worth $273. The position accounts for ﹤0.01% of the portfolio, ranked #7522.

Osaic Holdings first reported a position in NMTC in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.25K in Q3 2024. 32 funds tracked by Wall St. Rank hold NMTC as of Q1 2026.

  • Osaic Holdings held 58 shares of NeuroOne Medical Technologies worth $273 as of Q1 2026.
  • Osaic Holdings left its NeuroOne Medical Technologies share count unchanged in Q1 2026.
  • NeuroOne Medical Technologies made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7522 holding.
  • Osaic Holdings first reported a position in NeuroOne Medical Technologies in Q4 2022 and has held it in 14 quarters since.
  • Osaic Holdings's NeuroOne Medical Technologies position peaked at $1.25K in Q3 2024.
  • 32 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.